文献速递母胎医学产科

评估双胎输血综合征治疗的研究核心结局集

Core outcome set for research studies evaluating treatments for twin-twin transfusion syndrome.
PubMed 文献 · Ultrasound Obstet Gynecol · 2019-07-11

采用德尔菲法和名义群体技术制定双胎输血综合征治疗研究的核心结局集。来自29个国家的103名参与者参与三轮德尔菲调查,22个共识结局进入修改名义群体技术,最终确定12个核心结局及1个理想结局。作者认为实施该核心结局集可提升未来双胎输血综合征研究的实用性,尚需为各核心结局制定标准化定义和测量工具。

要点

  • 通过三轮德尔菲调查和修改名义群体技术,最终确定12个核心结局及1个理想结局。
  • 胎儿核心结局包括活产、妊娠丢失、单胎死亡后另一胎死亡、双胎输血综合征复发等。
  • 新生儿核心结局包括分娩孕周、出生体重、脑损伤综合征和缺血性肢体损伤。

核心结论

  • 在未来研究中实施双胎输血综合征核心结局集,可能对提升双胎输血综合征研究的实用性有实质贡献。
  • 目前尚需为各个核心结局制定标准化定义和测量工具。

研究设计与样本

  • 由医疗专业人员、研究人员和有双胎输血综合征经历的患者组成的国际指导组指导制定核心结局集。
  • 通过全面文献综述识别潜在核心结局,并由指导组补充建议的结局。
  • 开展三轮德尔菲调查,邀请医疗专业人员、研究人员及有双胎输血综合征经历的患者或亲属参与。
  • 共识预先采用核心结局测量在有效性试验中的倡议(COMET)15%/70%定义。
  • 采用修改名义群体技术在面对面咨询会议上评估共识结局并确定最终核心结局集。

主要发现

  • 来自29个国家的103名参与者参与三轮德尔菲调查,其中88人完成全部三轮。
  • 德尔菲程序识别出22个共识结局并进入修改名义群体技术。
  • 共识会议有11名医疗专业人员、2名研究人员和3名患者参加,12个核心结局被优先纳入核心结局集。
  • 胎儿核心结局包括活产、妊娠丢失(包括流产、死胎、终止妊娠和新生儿死亡)、治疗时单胎死亡后另一胎随后死亡、双胎输血综合征复发、双胎贫血-红细胞增多序列征和羊膜带综合征。
  • 新生儿核心结局包括分娩孕周、出生体重、脑损伤综合征和缺血性肢体损伤;母亲核心结局包括母亲死亡和入住2级或3级护理机构;另优先纳入1个理想结局,即18-24月龄神经发育。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop, using a Delphi procedure and a nominal group technique, a core outcome set (COS) for studies evaluating treatments for twin-twin transfusion syndrome (TTTS), which should assist in standardizing outcome selection, collection and reporting in future research studies. METHODS: An international steering group comprising healthcare professionals, researchers and patients with experience of TTTS guided the development of this COS. Potential core outcomes, identified through a comprehensive literature review and supplemented by outcomes suggested by the steering group, were entered into a three-round Delphi survey. Healthcare professionals, researchers, and patients or relatives of patients who had experienced TTTS were invited to participate. Consensus was defined a priori using the 15%/70% definition of the Core Outcome Measures in Effectiveness Trials (COMET) initiative. The modified nominal group technique was used to evaluate the consensus outcomes in a face-to-face consultation meeting and identify the final COS. RESULTS: One hundred and three participants, from 29 countries, participated in the three-round Delphi survey. Of those, 88 completed all three rounds. Twenty-two consensus outcomes were identified through the Delphi procedure and entered into the modified nominal group technique. The consensus meeting was attended by 11 healthcare professionals, two researchers and three patients; 12 core outcomes were prioritized for inclusion in the COS. Fetal core outcomes included live birth, pregnancy loss (including miscarriage, stillbirth, termination of pregnancy and neonatal mortality), subsequent death of a cotwin following single-twin demise at the time of treatment, recurrence of TTTS, twin anemia-polycythemia sequence and amniotic band syndrome. Neonatal core outcomes included gestational age at delivery, birth weight, brain injury syndromes and ischemic limb injury. Maternal core outcomes included maternal mortality and admission to Level-2 or -3 care setting. One aspirational outcome, neurodevelopment at 18-24 months of age, was also prioritized. CONCLUSIONS: Implementing the COS for TTTS within future research studies could make a substantial contribution to advancing the usefulness of research in TTTS. Standardized definitions and measurement instruments are now required for individual core outcomes. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Perry H, Duffy JMN, Reed K, et al. Core outcome set for research studies evaluating treatments for twin-twin transfusion syndrome. Ultrasound Obstet Gynecol. 2019. PMID: 30520170. doi:10.1002/uog.20183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。